Clinical trials
Recruiting Observational trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
225 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 3 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 9 |
| 2021 | 16 |
| 2022 | 21 |
| 2023 | 13 |
| 2024 | 37 |
| 2025 | 53 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 225 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Warsaw | 19 |
| Jagiellonian University | 15 |
| Medical University of Gdansk | 6 |
| Wroclaw Medical University | 6 |
| University of Alberta | 5 |
| Medical University of Bialystok | 4 |
| Miedziowe Centrum Zdrowia SA | 4 |
| Affidea Nu-med Center of Oncological DIagnostics and Therapy | 3 |
| AstraZeneca | 3 |
| Bartosz M. Radtke | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 9 |
| Heart Failure | 9 |
| Atrial Fibrillation | 7 |
| Neoplasms | 6 |
| Metabolic Syndrome | 5 |
| Prostatic Neoplasms | 5 |
| Ischemic Stroke | 4 |
| Parkinson Disease | 4 |
| Acute Coronary Syndrome | 3 |
| Aortic Valve Stenosis | 3 |
Trials
Showing 1 to 25 of 225. Each trial links to its page on Pharma Observatory.
125 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.